Skip to Content

Apollo Endosurgery, Inc.

Merger

  • Date:
  • 11/29/2022
  • Company Name:
  • Apollo Endosurgery, Inc.
  • Stock Symbol:
  • APEN
  • Company Name - Buyer:
  • Boston Scientific Corporation
  • Stock Symbol - Buyer:
  • BSX
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 11/29/2022

Case Finder

Locate any case using the tools below.

NEW YORK, November 29, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Apollo Endosurgery, Inc. (NASDAQ: APEN) (“Apollo Endosurgery”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Boston Scientific Corporation (NYSE: BSX) (“Boston Scientific”).

On November 29, 2022, Apollo Endosurgery announced that it had entered into an agreement to be acquired by Boston Scientific in an all-cash deal valued at $615 million. Pursuant to the merger agreement, Boston Scientific will acquire Apollo Endosurgery for $10.00 per share in cash. The deal is expected to close in the first half of 2023.

Bragar Eagel & Squire is concerned that Apollo Endosurgery’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Apollo Endosurgery’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Apollo Endosurgery. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: